Latest Videos |view all videos
Mark A. Frye, M.D., chair of the Department of Psychiatry and Psychology, discusses the Mayo Clinic Center for Individualized Medicine's Biobank for Bipolar Disorder.
Mayo Clinic psychiatrist Mark A. Frye, M.D., discusses how to best optimize lithium treatment. Lithium is a mainstay in bipolar disorder treatment and is commonly used to augment antidepressants for major depressive disorder. Research ...
Bipolar disorder and borderline personality disorder are complex disorders that are often interrelated and difficult to differentiate.
Many people with depression do not respond effectively to first line antidepressant treatments. It usually takes at least three weeks from the time treatment begins for those who do respond to see any clinical benefit.
Most psychiatrists agree that the ideal treatment for bipolar patients includes a healthy mix of medication and therapy. But is that what usually happens? Jennifer L. Vande Voort, M.D., at Mayo Clinic, posed that question.
J. Michael Bostwick, M.D., professor of psychiatry at Mayo Clinic's campus in Rochester, Minnesota, discusses his article, published in Mayo Clinic Proceedings, on a generalist's guide to treating patients with depression.
Tanya M. Brown, Ph.D., L.P., of Mayo Clinic's Department of Psychology, and Shari Wade, Ph.D., of Cincinnati Children's, discuss pediatric and adolescent traumatic brain injury (TBI), and emerging trends in TBI care.
Mayo Clinic clinical psychologist Leslie A. Sim, Ph.D., L.P., discusses family-based therapy for anorexia nervosa.
Amit Sood, MD, MSc, and Charanjit (Chet) Rihal, MD, MBA, discuss ways in which medical institutions can address physician stress and burnout.
Paul E. Croarkin, D.O., M.S., discusses noninvasive brain stimulation and repetitive transcranial magnetic stimulation for adolescent depression.
Jacob J. Strand, M.D., a general internist from the Section of Palliative Care Medicine at Mayo Clinic in Rochester, Minnesota, explains the role of palliative care in catastrophic illnesses.
Jeffrey P. Staab, M.D., Mayo Clinic psychiatrist, discusses the concepts that led to the development of the new terminology for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
Jeffrey P. Staab, M.D., Mayo Clinic psychiatrist, discusses core features and treatment strategies of somatic symptom disorders.
Jeffrey P. Staab, M.D., Mayo Clinic psychiatrist, discusses the responsibilities of psychologists, psychiatrists and primary care physicians in managing patients with functional and somatic symptom disorders.
Dr. Timothy Beebe Ph.D., Joseph Wick, Principle Business Analyst, and Ann Harris, Associate Director Conducting High Quality Surveys at Mayo Clinic: A Review of Best Practices and Available Resources.